Resumo

DE SOUZA-MODESTO, Thiago. Prescription of drugs with no proven efficacy in the fight against COVID-19 in Brazil: can we talk about conflict of interest?. Rev. Bioética y Derecho [online]. 2022, n.54, pp.199-214.  Epub 12-Dez-2022. ISSN 1886-5887.  https://dx.doi.org/10.1344/rbd2021.54.35024.

The search for drugs and vaccines to help combat COVID-19 became a reality after the World Health Organization (WHO) declared a Coronavirus pandemic on 11/03/2020. This shocking event in our lives has emphasized the importance of science for the maintenance of life and health for all. WHO recommendations have become a constant on the News, especially since we are dealing with a new and frightening situation. In accordance with its transnational characteristic, the pandemic reinforces that investment in research in the medical and health field is vital for the maintenance and realization of the fundamental rights of the human condition itself: life and health. In this context, this article aims, without pretending to exhaust the vast subject, to identify the possibility of conflicts of interest in the prescription of drugs without scientific proof of their effectiveness in the treatment of COVID-19, which generates harmful impacts on Society.

Palavras-chave : Science; conflict of interest; COVID-19; problematic; drugs; doctor-patient relationship.

        · resumo em Português | Catalão | Espanhol     · texto em Português     · Português ( pdf )